False hope for dry eye?

Article

An OTEurope story we ran a couple of weeks ago clearly resonated with reader, Peter Raus in Belgium. Read on to see what he thought.

An OTEurope story we ran a couple of weeks ago clearly resonated with reader, Peter Raus in Belgium. He writes:

"The title of the article 'Not a dry eye in the house' gives the false hope (again) that dry eye only is an immunologic problem… We all know that inflammatory expansion of B and T lymphocytes can lead to loss of lacrimal acini but this is only one aspect of an (unfortunately) far more complex phenonomenon that 'dry eye' appears to be! Personally I am convinced that a lot of other factors as e.g. lacritin play a more important role in the physiopathology of dry eyes. Moreover, acinar volume loss often appears insufficient relative to the theoretical overcapacity of the main lacrimal gland! On the other hand I welcome every new therapy that can help (and this is not the same as 'treat') my dry eye patients.'
Peter Raus, BELGIUM

We'd like to know what you think click here to let us know your experience.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.